Skip to main content

Profits before people? Vaccine diplomacy: Why is Modi govt losing out globally


By Shobha Shukla, Bobby Ramakant, Sandeep Pandey*

Narendra Modi once said he is a Gujarati and understands business. As time passes his business model is getting exposed and he is becoming more shameless like any ordinary businessman. It is quite clear to the people that he is not withdrawing the three controversial farm laws because all the three laws are meant to benefit the private corporations at the cost of farmers.
In fact, the farmers’ movement has also openly targeted Adani and Ambani in addition to Narendra Modi as their enemies. Graphic flex banners are visible at the protest sites at Singhu and Tikri.
Modi government very smartly made changes in political donation rules. Donations could now be made in the form of electoral bonds through an opaque system. In the name of protecting donors, it was not possible to find out the details of donations made even under Right to Information Act, India’s transparency law.
In addition, for companies making political donations the limit of 7.5% on average profit of past three years was done away with. Under this new system the political parties are exempt from reporting any donation above Rs 20,000 to the Election Commission, a requirement otherwise, if it is received in the form of electoral bonds.
Farmers suspect that Bhartiya Janata Party has received huge donations from Ambani and Adani through this anti-democratic and unethical system created by it and therefore its hands are tied when it comes to considering repeal of the three farms laws.
The same quid pro quo system is on display in Covid vaccine purchases now. Serum Institute and Bharat Biotech are the new beneficiaries chosen by the Modi government. In times of unprecedented crisis when people are tormented to the extreme, the two private companies have announced the prices at which they will sell the vaccines to government and private hospitals.
The question is why is the government giving them a free hand? Former Finance Minister P Chidambaram has suggested that the government should invoke compulsory licensing and invite price bids from other pharmaceutical manufacturers to reveal the true cost of the vaccines.
Most opposition state governments have opposed this differential pricing system for central government (Rs 150), state governments (Rs 400 for Covishield and Rs 600 for Covaxin), private hospitals (Rs 600 for Covishield and Rs 1200 for Covaxin), and for foreign buyers. But BJP governments – like the one in Uttar Pradesh – has gone ahead and announced that it will procure 1 crore vaccines, half each from Serum and Bharat Biotech.
Why is Yogi Adityanath wasting precious public resources on arbitrary prices set by two companies? Why is he not asking the Prime Minister to procure the vaccines at a price at which they were sold so far, Rs 150 per dose, and supply to him so that his government can vaccinate people for free. Mass production is supposed to bring down prices. But defying this normal principle Serum and Bharat Biotech have increased their prices as their production capacities have gone up.
Adar Poonawalla, the new blue eyed boy of Modi, has announced that in order to save thousands of crores of state funds and countless lives by vaccination he is reducing the price at which the vaccine will be sold by his company Serum to state governments from Rs 400 to Rs 300 per dose. Isn’t it an admission that Adar Poonawalla is profiteering at the expense of public money and depriving people of life by escalating the price of vaccine? People expect from Adar Poonawalla to save more government money and more lives.
Let us not forget that 97% of research and development of Covishield was done by AstraZeneca/Oxford using public funding
Former Health Secretary . Sujatha Rao has questioned the wisdom of central government abdicating its responsibility and passing it on to state governments and private sector to inoculate a major chunk of population between the ages of 18 and 44 years. She finds it preposterous that state governments are expected to buy vaccines at rates decided by private companies.
Senior journalist Karan Thapar has accused the government of indulging in tactical game playing by first reaching an agreement with Serum Institute to buy 10 crore vaccines last year but placing an order for only 1 to 2 crores each time. This, when a sum of Rs 35,000 crores had been set aside for vaccination in the budget and unknown amount is lying with PM Cares fund.
The abysmally low rate of vaccination of the much touted ‘world’s largest vaccination programme’ is because of the government dragging its feet and trying to act smart. Looks like the businessman in Modi got the better of the statesman in him.
Modi government took credit earlier this month when it announced that from of May 1, 2021, everyone above 18 years of age in the country will be eligible to get a vaccine. 
But on April 23, 2021, Rajesh Bhushan, Secretary in the Ministry of Health and Family Welfare in central government wrote a letter to all the states and union territories that the vaccination for 18-44 years will only be available in private sector in the country (for which people have to pay of course), and if the state or union territory wants to offer it in government healthcare services then they will have to procure the vaccine at the inflated rate directly from the manufacturer(s).
Moreover, all over the world there is strong precedence when so many countries have pooled in their demands for medicines or diagnostics or vaccines for global price negotiations at the lowest possible rate to ensure that the same high quality of affordable medicines or diagnostics or vaccines are offered in all those countries. But Modi government is doing just the opposite to benefit the chosen corporations.
Let us not forget that 97% of research and development of Covishield was done by AstraZeneca/Oxford using public funding, due to which it was promised that the vaccine will be rolled out at no profit. But Adar Poonawalla wants to mint ‘super profit’ as told by him in a news.
Also, the essential part of research for Covaxin was done in government’s National Institute of Virology (an Indian Council of Medical Research institute), and then it was handed over to Bharat Biotech for further development. We wonder if the government owns the intellectual property rights for Covaxin because it was the government (and not Bharat Biotech) which chose additional manufacturer for Covaxin, Haffkine.
If it is so, then Modi government is losing a golden opportunity to scale higher standards of ‘vaccine diplomacy’ worldwide – it should immediately allow every other manufacturer within India and worldwide who wants to make Covaxin and help fight the pandemic. If the government fails to do so, then it will further expose its agenda of putting profits before people.
---
*Shobha Shukla is with Citizen News Service (CNS); Bobby Ramankant is with CNS and Socialist Party (India); Sandeep Pandey, a Magsaysay award winning social activist, is with Socialist Party (India)

Comments

TRENDING

Academics urge Azim Premji University to drop FIR against Student Reading Circle

  By A Representative   A group of academics and civil society members has issued an open letter to the leadership of Azim Premji University expressing concern over the filing of a police complaint that led to an FIR against a student-run reading circle following a recent incident of violence on campus. The signatories state that they hold the university in high regard for its commitment to constitutional values, critical inquiry and ethical public engagement, and argue that it is precisely because of this reputation that the present development is troubling.

'Policy long overdue': Coalition of 29 experts tells JP Nadda to act on SC warning label order

By A Representative   In a significant development for public health, the Supreme Court of India has directed the Food Safety and Standards Authority of India (FSSAI) to seriously consider implementing mandatory front-of-pack warning labels on pre-packaged food products. The order, passed by a bench of Justices J.B. Pardiwala and K.V. Viswanathan on February 10, 2026, comes as the Court expressed dissatisfaction with the regulatory body's progress on the issue.

Vaccination vs screening: Policy questions raised on cervical cancer strategy

By A Representative   A public policy expert has written to Union Health Minister J. P. Nadda raising a series of concerns regarding the national Human Papillomavirus (HPV) vaccination campaign launched on February 28 for 14-year-old girls.

UAPA action against Telangana activist: Criminalising legitimate democratic activity?

By A Representative   The National Investigation Agency's Hyderabad branch has issued notices to more than ten individuals in Telangana in connection with FIR No. RC-04/2025. Those served include activists, former student leaders, civil rights advocates, poets, writers, retired schoolteachers, and local leaders associated with the Communist Party of India (CPI) and the Indian National Congress. 

The new anti-national certificate: If Arundhati Roy is the benchmark, count me in

By Dr. Mansee Bal Bhargava*   Dear MANIT Alumni Network Committee, “Are you anti-national?” I encountered this fascinating—some may say intimidating—question from an elderly woman I barely know, an alumna of Maulana Azad College of Technology (MACT, now Maulana Azad National Institute of Technology - MANIT), Bhopal, and apparently one of the founders of the MACT (now MANIT) Alumni Network. The authority with which she posed the question was striking. “How much anti-national are you? What have you done for the Alumni Network Committee to identify you as anti-national?” When I asked what “anti-national” meant to her and who was busy certifying me as such, the response came in counter-questions.

Development vs community: New coal politics and old conflicts in Madhya Pradesh

By Deepmala Patel*  The Singrauli region of Madhya Pradesh, often described as “India’s energy capital,” has for decades been a hub of coal mining and thermal power generation. Today, the Dhirouli coal mine project in this district has triggered widespread protests among local communities. In recent years, the project has generated intense controversy, public opposition, and significant legal and social questions. This is not merely a dispute over one mine; it raises a larger question—who pays the price for energy development? Large corporate beneficiaries or the survival of local communities?

Minority concerns mount: RTI reveals govt funded Delhi religious meet in December

By Syed Ali Mujtaba*  Indian Muslims have expressed deep concern over what they describe as rising hate speech and hostility against their community under the BJP-led government in India. A recent flashpoint was the event organised by Sanatan Sanstha titled “Sanatan Rashtra Shankhnad Mahotsav” in New Delhi on 13–14 December 2025.

Buddhist shrines were 'massively destroyed' by Brahmanical rulers: Historian DN Jha

Nalanda mahavihara By Rajiv Shah  Prominent historian DN Jha, an expert in India's ancient and medieval past, in his new book , "Against the Grain: Notes on Identity, Intolerance and History", in a sharp critique of "Hindutva ideologues", who look at the ancient period of Indian history as "a golden age marked by social harmony, devoid of any religious violence", has said, "Demolition and desecration of rival religious establishments, and the appropriation of their idols, was not uncommon in India before the advent of Islam".

From neglect to progress: The story of Ranavara’s community-led development

By Bharat Dogra   Visitors to Ranavara, a remote village in Kherwara block of Udaipur district, are often surprised by its multi-dimensional progress. The village today is known for its impressive school building, regenerated pastures, expanded tree cover, and extensive water conservation and supply works. These achievements are the outcome of sustained community efforts over several years, demonstrating how small, consistent initiatives can lead to significant change.